AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 190 filers reported holding AURINIA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,882,046 | -63.1% | 628,320 | -54.1% | 0.01% | -60.6% |
| Q2 2023 | $13,243,895 | +67.0% | 1,368,171 | +89.1% | 0.03% | +43.5% |
| Q1 2023 | $7,930,678 | +193.6% | 723,602 | +15.7% | 0.02% | +187.5% |
| Q4 2022 | $2,700,747 | -31.5% | 625,173 | +19.3% | 0.01% | -38.5% |
| Q3 2022 | $3,942,000 | +2348.4% | 524,246 | +4710.0% | 0.01% | +1200.0% |
| Q3 2020 | $161,000 | -54.9% | 10,899 | -55.7% | 0.00% | -66.7% |
| Q1 2020 | $357,000 | -91.1% | 24,599 | -95.5% | 0.00% | -78.6% |
| Q1 2017 | $4,028,000 | – | 548,771 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 230,000 | $993,600 | 1.92% |
| AlphaCentric Advisors LLC | 352,500 | $1,522,800 | 1.50% |
| NEA Management Company, LLC | 3,969,834 | $17,149,683 | 0.96% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 573,530 | $2,477,650 | 0.76% |
| ARMISTICE CAPITAL, LLC | 5,000,000 | $21,600,000 | 0.38% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 93,658 | $404,603 | 0.27% |
| Artal Group S.A. | 1,000,000 | $4,320 | 0.24% |
| Virtus ETF Advisers LLC | 64,786 | $279,876 | 0.15% |
| TANG CAPITAL MANAGEMENT LLC | 200,000 | $864,000 | 0.13% |
| HighMark Wealth Management LLC | 37,499 | $161,996 | 0.12% |